STAA heads into its August 12 earnings report with a notable gap opening between where options traders are leaning and where short sellers are sitting.
The sharpest signal this week is in options. The put/call ratio has jumped to 0.42, well above its 20-day average of 0.37 — and at 2.76 standard deviations above that mean, it ranks as one of the more defensive readings STAA options have shown all year. That shift comes directly on the heels of an 11% drop in the stock over the past week, with shares closing at $24.27. The move has taken STAA down more than 16% over the past month, widening the gap to analyst targets considerably. Options traders are clearly buying more downside protection than usual heading into what should be a closely watched print.
Short interest tells a less anxious story, however. Bears have actually been trimming. SI now covers roughly 10.4% of the free float — still a high absolute level — but positions are down about 2.7% on the week and nearly 4.4% over the past month. Borrowing costs have eased too, falling 14.5% on the week to just 0.43%. Availability in the lending market is ample, running at 231% of shares short — meaning there are more than two shares available to borrow for every one already lent out. That is well above the 52-week tightest reading of 129%. The lending market, in short, is relaxed even if the stock is not. Short sellers appear to be covering into the weakness rather than pressing.
The Street is split, but leans cautiously bullish. Wedbush reiterated its Outperform and $40 target this week — a 65% premium to the current price — maintaining conviction after the recent selloff. The consensus rating remains a hold, with seven analysts at that level and a mean price target of $30. That $30 target still implies meaningful upside from $24.27, but it also reflects a Street that sees the stock as fairly priced under a base case rather than one clamouring to own it. The bull case centres on STAA's ICL franchise recovering in China and a demonstrated earnings beat in Q1 2026, when the stock jumped 13.6% the day results dropped and extended to a 17.3% gain over the following five days. The bear case points to emerging competition from EyeBright in China and management's persistent reluctance to issue formal guidance — a pattern that keeps uncertainty elevated at each quarterly print.
Institutional positioning adds an interesting wrinkle. Point72 disclosed a position of 2.59 million shares as of May, built through an addition of 1.77 million shares — a meaningful accumulation from one of the market's better-known multi-strategy funds. Madison Avenue Partners reported an entirely new position of 2.85 million shares in the same period. Those moves suggest some active managers used the stock's earlier weakness as a buying opportunity, though neither position has been updated since the recent leg lower. EPS momentum factor scores remain strong — ranking in the 96th percentile on a 90-day basis — but the short score of 68.1 has been drifting down from a recent high near 70.2, consistent with the small but steady short covering.
With earnings due August 12, the key tension is whether the Q1 momentum — that outsized day-one reaction — carries through into Q2 results, or whether management's continued silence on guidance keeps the put buyers in charge ahead of the print.
See the live data behind this article on ORTEX.
Open STAA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
